CD34 and disease arising from reactivation of latent virus: In both primary and hESC-derived CD34+ HPCs infected with HCMV HB-K223A or HCMV HB-R225A, we observed deficits in the ability of the virus to efficiently reactivate from latent infection when compared with wild-type-infected cells (Fig. 6A; Fig. S7).